Pioneering study shows promising results for cognitive treatment in Down syndrome

The ICOD (Improving Condition in Down syndrome) project, a pioneering study in addressing the cognitive difficulties associated with Down syndrome, has demonstrated the safety of treatment with the molecule AEF0217, developed by the French biotech Aelis Farma, as well as its effectiveness in improving cognitive function in these people.

Kate Middleton Gives Cancer Update

Kate Middleton, the Princess of Wales said Friday she is “making good progress” in her cancer treatment and will attend Saturday’s royal Trooping the Color

June 15, 2024

Biotech layoffs, slumping stocks, and a 2024 preview

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024? We cover all that and

January 18, 2024

Lutris wins FDA orphan drug tag for EGFR inhibitor-induced rash candidate – Pharmaceutical Technology

Share this article According to Lutris’ CEO, approximately 75% of cancer patients taking EGFR inhibitors develop some form of acneiform rash. Credit: sruilk via Getty

February 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.